KIMBERLY RICHE: Open Payments
NPI 1790127504 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,130 in 123 payments from 27 companies in 2025. Trend: 2023 $960 · 2024 $980 · 2025 $2,130
Food & beverage: $1,787Travel & lodging: $173Education: $170
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $451 |
| UCB, Inc. | 13 | $228 |
| Abbott Laboratories | 4 | $181 |
| ACADIA Pharmaceuticals Inc | 24 | $172 |
| JAZZ PHARMACEUTICALS INC. | 5 | $169 |
| Neurocrine BioSciences, Inc. | 16 | $168 |
| HARMONY BIOSCIENCES LLC | 1 | $70 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Amneal Pharmaceuticals LLC | 3 | $60 |
| GENZYME CORPORATION | 2 | $49 |
Products named: QULIPTA, INFINITY, NUPLAZID, XYWAV, INGREZZA, Fintepla, UBRELVY, CREXONT.
Industry payments across LA — which companies pay providers there.
